The aim of the present study was to test for an association between the Asn118Asn (ERCC1), Lys751Gln and Asp312Asn (ERCC2) variants, and osteosarcoma and colorectal and breast cancer in Mexican patients. Here, ERCC2 is linked to osteosarcoma.